Report Update Nov 1, 2024

Sweden - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Sweden: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Sweden

The Swedish medicaments containing insulin market contracted slightly to $X in 2021, which is down by -1.8% against the previous year. In general, consumption, however, saw a relatively flat trend pattern. As a result, consumption attained the peak level of $X. From 2018 to 2021, the growth of the market remained at a lower figure.

Medicaments Containing Insulin Production in Sweden

In value terms, medicaments containing insulin production reduced modestly to $X in 2021 estimated in export price. Overall, production posted strong growth. The most prominent rate of growth was recorded in 2016 when the production volume increased by 47%. Medicaments containing insulin production peaked at $X in 2020, and then dropped in the following year.

Medicaments Containing Insulin Exports

Exports from Sweden

In 2021, overseas shipments of medicaments containing insulin but not antibiotics decreased by -44.4% to X kg for the first time since 2018, thus ending a two-year rising trend. Over the period under review, exports showed a sharp decline. The most prominent rate of growth was recorded in 2014 when exports increased by 2,906% against the previous year. As a result, the exports reached the peak of X kg. From 2015 to 2021, the growth of the exports remained at a somewhat lower figure.

In value terms, medicaments containing insulin exports declined notably to $X in 2021. Overall, exports showed a noticeable descent. The most prominent rate of growth was recorded in 2014 when exports increased by 4,927% against the previous year. As a result, the exports attained the peak of $X. From 2015 to 2021, the growth of the exports failed to regain momentum.

Exports by Country

The United States (X kg) was the main destination for medicaments containing insulin exports from Sweden, with a 70% share of total exports. Moreover, medicaments containing insulin exports to the United States exceeded the volume sent to the second major destination, Canada (X kg), fourfold.

From 2012 to 2021, the average annual growth rate of volume to the United States stood at +24.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: Canada (-33.3% per year) and Switzerland (0.0% per year).

In value terms, the United States ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from Sweden, comprising 94% of total exports. The second position in the ranking was taken by Canada ($X), with a 1.8% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to the United States stood at +63.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Canada (-31.7% per year) and Switzerland (0.0% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, with a decrease of -33.2% against the previous year. Over the period under review, the export price, however, posted a significant increase. The growth pace was the most rapid in 2015 when the average export price increased by 292%. Over the period under review, the average export prices attained the maximum at $X per ton in 2020, and then contracted sharply in the following year.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the United States ($X per ton), while the average price for exports to Switzerland ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United States (+33.9%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into Sweden

In 2019, imports of medicaments containing insulin but not antibiotics into Sweden skyrocketed to X kg, growing by 101% compared with the previous year. In general, imports, however, saw a pronounced descent. The most prominent rate of growth was recorded in 2017 when imports increased by 573% against the previous year. As a result, imports reached the peak of X tons. From 2018 to 2019, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2019. Overall, imports, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 when imports increased by 834%. As a result, imports attained the peak of $X. From 2018 to 2019, the growth of imports remained at a lower figure.

Imports by Country

From 2012 to 2021, the average annual growth rate of volume from No country was relatively modest.

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Sweden.

From 2012 to 2021, the average annual rate of growth in terms of value from the United States totaled -64.3%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, stabilizing at the previous year. In general, the import price recorded a deep reduction. The pace of growth was the most pronounced in 2019 an increase of 104% against the previous year. As a result, import price reached the peak level of $X per ton. From 2020 to 2021, the average import prices failed to regain momentum.

As there is only one major supplying country, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for the UK amounted to +16.6% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin consumption was Denmark, accounting for 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. Pakistan ranked third in terms of total production with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to Sweden?

In value terms, Switzerland constituted the largest supplier of medicaments containing insulin to Sweden, comprising 52% of total imports. The second position in the ranking was occupied by Austria, with a 19% share of total imports. It was followed by the UK, with a 9.2% share.

What are the leading importers of medicaments containing insulin but not antibiotics from Sweden?

In value terms, the U.S. emerged as the key foreign market for medicaments containing insulin exports from Sweden, comprising 91% of total exports. The second position in the ranking was occupied by Norway, with a 9.4% share of total exports.

What is the average export price for medicaments containing insulin but not antibiotics in Sweden?

The average medicaments containing insulin export price stood at $100,543 per ton in 2020, with an increase of 17% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Sweden?

In 2019, the average medicaments containing insulin import price amounted to $42,662 per ton, increasing by 91% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Sweden. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Sweden

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Sweden
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023